Skip to content

Primary Diagnosis Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

Clinical Validation for Non-Inferiority of Primary Diagnosis by WSI Hamamatsu NanoZoomer S360MD Digital Slide Scanner System Compared to Conventional Determination by Light Microscope

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03991468
Enrollment
2000
Registered
2019-06-19
Start date
2019-03-15
Completion date
2021-07-31
Last updated
2022-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathology

Brief summary

The primary objective of this study is to evaluate the safety and accuracy of the Hamamatsu WSI compared to those of the reference method (conventional light microscope (Glass)) under clinical use conditions as an aid for pathologists to view, review and diagnose digital images of surgical pathology slides. The primary endpoint is the indicator of major discordance in primary diagnosis between ground truth case diagnosis and case diagnosis by each modality, WSI and Glass, separately.

Interventions

DIAGNOSTIC_TESTWhole Slide Imaging

Scanning of a glass slide to create a digital image that can be viewed on a monitor

DIAGNOSTIC_TESTLight Microscopy

Use of traditional light microscopy per institutional standard practice

Sponsors

Hamamatsu Photonics K.K.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Masking description

Adjudicators are blinded to the imaging modality.

Intervention model description

Cases are assessed using both glass slide light microscopy and NanoZoomer digital whole slide imaging in a random order

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Cases originating from and that were diagnosed at that local site * Cases are available in the site's archive * Cases are at least 1 year old since accessioning * Cases are selected because their primary diagnosis is consistent with the assigned target categories * Cases have a set of slides representative of the primary diagnosis for which it has been selected Slide selection for a given case must meet the following criteria: * Slide is obtained by surgical pathology and prepared from FFPE human tissue * Slides must be stained with H&E and accompanying special stains (histochemical and/or immunohistochemical) * All special stains slides (histochemical and/or immunohistochemical) where the slide and stain is used for diagnosis, not prognosis. * A chosen slide must demonstrate and be representative of the primary diagnosis; 1 slide selection may suffice for biopsy cases, * For resection cases, a minimum of 5 slides must be selected, which represent the primary diagnosis. If represented with less than 5 slides, additional slides (primary, secondary, or benign slides) from same case may be used to fulfill minimum number * Slide is intact, has correct size/thickness, good edges, undamaged coverslip, without pen markings that can't be removed, no air bubbles, tidy labels, and fulfills the quality checks per the general clinical practice

Exclusion criteria

* Case does not have relevant slides or if case information necessary for the study is missing * Case is still active (less than 1 year old) at the local site * Cases for which the control slides for immunohistochemistry and special stains are not available * Two cases from same individual * Gross-only cases that have no slides * Cases that are frozen section, cytology or hematology or immunofluorescence specimens only * Case where the only available set of slides have evidence only of secondary or no diagnoses and not the primary diagnosis for which the case is being screened. Slides for a given case will be excluded if they meet the following criterion: • Glass slide that is broken, has abnormal size/thickness, beveled edges, poor coverslip (cracks, waviness, scratches), is sticky, has many pen markings or dirt that cannot be removed, contains air bubbles and overhanging labels that can't be corrected, and if stain is severely faded.

Design outcomes

Primary

MeasureTime frameDescription
Major Discordance Rate1 dayIndpendent reads by four Reading Pathologists (RPs) of both imaging modalitites (8 reads/case) were compared to the original diagnosis (ground truth or GT) by an independent adjudication process. This resulted in one of four adjudication outcomes for each read: Match (read = GT), Minor (minor discordance between read & GT), Major (major discordance between read & GT), or Deferred (read deferred by RP and excluded from the primary endpoint analysis). The outcome measure was the rate at which major discordances occurred for each modality.

Countries

United States

Participant flow

Pre-assignment details

Cases were assessed using both glass slide light microscopy and digital whole slide imaging in a random sequence. Therefore, each case had 2 primary diagnoses in the study.

Participants by arm

ArmCount
All Cases
All cases were assessed via Whole Slide Imaging using the Hamamatsu NanoZoomer S360MD Digital Slide Scanner System to assess pathological characteristics of scanned slides and traditional light microscopy using glass slides. The order in which each modality is used was randomly assigned.
2,000
Total2,000

Baseline characteristics

CharacteristicAll Cases
Age, Continuous59.6 Years
STANDARD_DEVIATION 14.8
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
2000 participants
Sex: Female, Male
Female
1046 Participants
Sex: Female, Male
Male
954 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Major Discordance Rate

Indpendent reads by four Reading Pathologists (RPs) of both imaging modalitites (8 reads/case) were compared to the original diagnosis (ground truth or GT) by an independent adjudication process. This resulted in one of four adjudication outcomes for each read: Match (read = GT), Minor (minor discordance between read & GT), Major (major discordance between read & GT), or Deferred (read deferred by RP and excluded from the primary endpoint analysis). The outcome measure was the rate at which major discordances occurred for each modality.

Time frame: 1 day

Population: Two modalities (glass \& WSI) are read by 4 reading pathologists at each site for a total of 16,000 reads. Any reads deferred by a reading pathologist are excluded.

ArmMeasureValue (NUMBER)
NanoZoomer Whole Slide ImagingMajor Discordance Rate3.5 Percentage of Major Discordances
Glass Slide Light MicroscopyMajor Discordance Rate3.1 Percentage of Major Discordances
95% CI: [-0.1, 1]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026